Nearly Half of Patients on Opioid Treatment Use Cannabis — Mostly to Manage Symptoms

47.5% of MOUD patients used cannabis, 27% frequently (≥3 days/week). Frequent use was associated with anxiety, nausea, and lower employment. Among those surveyed in depth, 56% used for both recreation and symptom management, 30% for symptom management only. Top medical reasons: stress (100%), anxiety (83%), insomnia (79%), pain (75%), depression (75%), PTSD (67%). No significant differences in MOUD outcomes.

Analysis of 303 participants from a randomized trial of a mind-body intervention adjunct to MOUD. Frequent cannabis users (≥3 days/week) were compared with less frequent/non-users on demographics and clinical characteristics. A subsample (n=27) completed detailed telephone surveys on cannabis use patterns and motivations.

Many opioid treatment programs discourage or penalize cannabis use, but most patients using it are self-medicating real symptoms. Understanding these motivations could shift policy toward addressing underlying conditions rather than policing cannabis use.

The finding that cannabis use doesn't worsen MOUD outcomes but patients are using it for untreated symptoms suggests a systemic failure — patients aren't getting adequate treatment for stress, anxiety, pain, and trauma, so they self-medicate with cannabis.

Cross-sectional design from a clinical trial population may not represent all MOUD patients. Small subsample (n=27) for detailed motivations. Self-reported cannabis use subject to bias. Cannot determine whether cannabis actually helps the reported symptoms.